Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Large-Cell, Anaplastic | 15 | 2024 | 169 | 3.760 |
Why?
|
Protein-Tyrosine Kinases | 25 | 2024 | 2423 | 2.940 |
Why?
|
Receptor Protein-Tyrosine Kinases | 25 | 2023 | 1624 | 2.650 |
Why?
|
Translocation, Genetic | 12 | 2024 | 1394 | 2.540 |
Why?
|
Oncogene Proteins, Fusion | 9 | 2024 | 1608 | 1.340 |
Why?
|
RNA Editing | 2 | 2023 | 148 | 1.210 |
Why?
|
Neuroblastoma | 5 | 2024 | 1263 | 1.150 |
Why?
|
Protein Kinase Inhibitors | 18 | 2024 | 5696 | 1.110 |
Why?
|
Cancer Vaccines | 4 | 2023 | 1044 | 1.050 |
Why?
|
Oncogenes | 3 | 2023 | 1235 | 1.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 8 | 2023 | 5389 | 1.000 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 11 | 2024 | 1434 | 0.990 |
Why?
|
Lymphoma | 14 | 2023 | 1897 | 0.970 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2024 | 228 | 0.950 |
Why?
|
cdc42 GTP-Binding Protein | 3 | 2018 | 187 | 0.920 |
Why?
|
Lymphoma, T-Cell | 6 | 2018 | 309 | 0.880 |
Why?
|
Burkitt Lymphoma | 2 | 2024 | 338 | 0.840 |
Why?
|
F-Box Proteins | 3 | 2021 | 199 | 0.800 |
Why?
|
Lymphoma, B-Cell | 4 | 2022 | 943 | 0.790 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2022 | 97 | 0.760 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2022 | 50 | 0.760 |
Why?
|
Lung Neoplasms | 13 | 2023 | 13451 | 0.740 |
Why?
|
Cell Line, Tumor | 33 | 2024 | 17075 | 0.730 |
Why?
|
Retroelements | 1 | 2022 | 163 | 0.730 |
Why?
|
Genetic Engineering | 3 | 2018 | 933 | 0.720 |
Why?
|
Neoplasms | 18 | 2024 | 22340 | 0.720 |
Why?
|
Immunoglobulin Heavy Chains | 4 | 2017 | 648 | 0.660 |
Why?
|
DNA Breaks, Double-Stranded | 7 | 2023 | 604 | 0.630 |
Why?
|
STAT3 Transcription Factor | 13 | 2020 | 870 | 0.620 |
Why?
|
rho GTP-Binding Proteins | 2 | 2022 | 280 | 0.620 |
Why?
|
Mice | 67 | 2024 | 81819 | 0.600 |
Why?
|
Tumor Suppressor Proteins | 6 | 2018 | 2796 | 0.600 |
Why?
|
B-Lymphocytes | 9 | 2019 | 4778 | 0.590 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2018 | 163 | 0.590 |
Why?
|
Cell Transformation, Neoplastic | 10 | 2023 | 2844 | 0.570 |
Why?
|
Aneuploidy | 1 | 2021 | 578 | 0.570 |
Why?
|
rac1 GTP-Binding Protein | 2 | 2016 | 246 | 0.540 |
Why?
|
Signal Transduction | 20 | 2024 | 23601 | 0.530 |
Why?
|
Lymphoma, Follicular | 2 | 2014 | 459 | 0.520 |
Why?
|
Genomic Instability | 2 | 2017 | 718 | 0.510 |
Why?
|
Animals | 80 | 2024 | 168764 | 0.500 |
Why?
|
Immunoglobulin Class Switching | 5 | 2018 | 289 | 0.480 |
Why?
|
Gene Expression Regulation, Neoplastic | 16 | 2024 | 8611 | 0.480 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 5 | 2014 | 1410 | 0.460 |
Why?
|
Antigens, Neoplasm | 5 | 2023 | 2002 | 0.460 |
Why?
|
Cell Proliferation | 13 | 2018 | 10429 | 0.450 |
Why?
|
Lymphoma, Mantle-Cell | 3 | 2023 | 238 | 0.430 |
Why?
|
Mice, SCID | 10 | 2022 | 2630 | 0.430 |
Why?
|
GRB2 Adaptor Protein | 2 | 2010 | 101 | 0.420 |
Why?
|
Immunoglobulins | 1 | 2016 | 852 | 0.410 |
Why?
|
Mice, Transgenic | 17 | 2023 | 9550 | 0.410 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 904 | 0.400 |
Why?
|
Thymus Neoplasms | 6 | 2014 | 270 | 0.400 |
Why?
|
Mice, Inbred NOD | 6 | 2022 | 1837 | 0.390 |
Why?
|
Chromosome Breakage | 2 | 2011 | 159 | 0.390 |
Why?
|
Gene Rearrangement | 3 | 2020 | 1144 | 0.380 |
Why?
|
Vaccines, DNA | 2 | 2013 | 279 | 0.380 |
Why?
|
Microtubule-Associated Proteins | 5 | 2017 | 1066 | 0.380 |
Why?
|
T-Lymphocytes | 12 | 2023 | 10261 | 0.380 |
Why?
|
B-Lymphocyte Subsets | 1 | 2013 | 241 | 0.370 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 752 | 0.370 |
Why?
|
Cell Cycle Proteins | 7 | 2017 | 3430 | 0.360 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2023 | 225 | 0.350 |
Why?
|
Neuropeptides | 1 | 2016 | 951 | 0.340 |
Why?
|
Humans | 125 | 2024 | 765968 | 0.340 |
Why?
|
Pyrazoles | 4 | 2017 | 2033 | 0.330 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2023 | 2878 | 0.330 |
Why?
|
Gene Silencing | 5 | 2013 | 1505 | 0.320 |
Why?
|
Vaccination | 4 | 2023 | 3426 | 0.310 |
Why?
|
Protein-Arginine N-Methyltransferases | 3 | 2021 | 127 | 0.310 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2024 | 5337 | 0.310 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 5 | 2022 | 190 | 0.300 |
Why?
|
Cell Shape | 2 | 2010 | 373 | 0.300 |
Why?
|
Apoptosis | 16 | 2017 | 9514 | 0.300 |
Why?
|
Mutation | 17 | 2024 | 30198 | 0.300 |
Why?
|
Antineoplastic Agents | 8 | 2022 | 13648 | 0.300 |
Why?
|
DNA-Binding Proteins | 11 | 2019 | 9601 | 0.290 |
Why?
|
Carcinoma, Pancreatic Ductal | 6 | 2021 | 1758 | 0.280 |
Why?
|
Mutagenesis | 1 | 2011 | 1228 | 0.280 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1874 | 0.280 |
Why?
|
Crk-Associated Substrate Protein | 2 | 2010 | 39 | 0.270 |
Why?
|
Genes, myc | 3 | 2021 | 393 | 0.270 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2020 | 2505 | 0.260 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2024 | 1646 | 0.260 |
Why?
|
Down-Regulation | 5 | 2018 | 2927 | 0.260 |
Why?
|
Cell Division | 7 | 2010 | 4475 | 0.260 |
Why?
|
Cadherins | 2 | 2024 | 900 | 0.260 |
Why?
|
Pyridines | 3 | 2015 | 2888 | 0.240 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2007 | 457 | 0.240 |
Why?
|
Phosphorylation | 14 | 2011 | 8278 | 0.240 |
Why?
|
Sepsis | 1 | 2018 | 2606 | 0.230 |
Why?
|
Lymphocytes | 3 | 2017 | 2599 | 0.230 |
Why?
|
Myelodysplastic-Myeloproliferative Diseases | 1 | 2024 | 15 | 0.230 |
Why?
|
Enzyme Activation | 4 | 2018 | 3586 | 0.230 |
Why?
|
Hematopoietic System | 1 | 2024 | 110 | 0.220 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2018 | 2880 | 0.220 |
Why?
|
Enzyme Inhibitors | 3 | 2018 | 3715 | 0.220 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 2 | 2018 | 102 | 0.220 |
Why?
|
Leukemia, Plasma Cell | 1 | 2003 | 46 | 0.220 |
Why?
|
MAP Kinase Signaling System | 3 | 2019 | 1490 | 0.220 |
Why?
|
Phosphopyruvate Hydratase | 3 | 2017 | 127 | 0.210 |
Why?
|
Genome | 1 | 2011 | 1753 | 0.210 |
Why?
|
Receptor, trkA | 1 | 2024 | 159 | 0.210 |
Why?
|
Receptors, CCR7 | 1 | 2023 | 104 | 0.210 |
Why?
|
Immunohistochemistry | 19 | 2020 | 11022 | 0.210 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2013 | 1376 | 0.210 |
Why?
|
HEK293 Cells | 5 | 2022 | 4260 | 0.210 |
Why?
|
Vaccines, Subunit | 1 | 2023 | 158 | 0.210 |
Why?
|
RNA Interference | 6 | 2016 | 2832 | 0.200 |
Why?
|
Proto-Oncogene Proteins | 4 | 2024 | 4520 | 0.200 |
Why?
|
Trans-Activators | 4 | 2005 | 2850 | 0.200 |
Why?
|
Leukemoid Reaction | 1 | 2022 | 18 | 0.200 |
Why?
|
Vimentin | 2 | 2016 | 258 | 0.200 |
Why?
|
Cytidine Deaminase | 2 | 2017 | 250 | 0.200 |
Why?
|
RNA, Small Interfering | 7 | 2011 | 3421 | 0.200 |
Why?
|
Genes, Immunoglobulin | 1 | 2023 | 285 | 0.200 |
Why?
|
Mice, Inbred BALB C | 7 | 2015 | 6220 | 0.200 |
Why?
|
Cell Movement | 5 | 2010 | 5194 | 0.200 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3946 | 0.190 |
Why?
|
Primary Myelofibrosis | 1 | 2024 | 210 | 0.190 |
Why?
|
Plasmacytoma | 1 | 2002 | 174 | 0.190 |
Why?
|
INDEL Mutation | 1 | 2023 | 268 | 0.190 |
Why?
|
Neoplasms, Experimental | 3 | 2014 | 1229 | 0.190 |
Why?
|
Recombination, Genetic | 3 | 2017 | 1525 | 0.190 |
Why?
|
Multienzyme Complexes | 2 | 2008 | 663 | 0.190 |
Why?
|
Cytoskeletal Proteins | 3 | 2018 | 1325 | 0.190 |
Why?
|
Cell Survival | 6 | 2018 | 5747 | 0.190 |
Why?
|
GATA1 Transcription Factor | 1 | 2022 | 306 | 0.180 |
Why?
|
S Phase | 1 | 2002 | 424 | 0.180 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2023 | 4642 | 0.180 |
Why?
|
Interleukin-10 Receptor alpha Subunit | 1 | 2020 | 28 | 0.180 |
Why?
|
Chromosomal Instability | 1 | 2021 | 175 | 0.170 |
Why?
|
Cytoskeleton | 1 | 2005 | 1178 | 0.170 |
Why?
|
Leukocyte Elastase | 1 | 2021 | 113 | 0.170 |
Why?
|
Endonucleases | 1 | 2023 | 372 | 0.170 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2018 | 1761 | 0.170 |
Why?
|
Estrogen Receptor alpha | 2 | 2023 | 578 | 0.170 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2016 | 3608 | 0.170 |
Why?
|
Receptors, Interleukin | 1 | 2021 | 243 | 0.170 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2015 | 498 | 0.170 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2018 | 612 | 0.150 |
Why?
|
Cyclin D1 | 1 | 2000 | 449 | 0.150 |
Why?
|
Janus Kinase 3 | 3 | 2011 | 75 | 0.150 |
Why?
|
Interferon-gamma | 5 | 2010 | 3160 | 0.150 |
Why?
|
Gene Amplification | 1 | 2023 | 1091 | 0.150 |
Why?
|
Lymph Nodes | 6 | 2017 | 3454 | 0.150 |
Why?
|
DNA Repair | 4 | 2023 | 2048 | 0.150 |
Why?
|
Base Sequence | 8 | 2016 | 12403 | 0.150 |
Why?
|
Down Syndrome | 2 | 2022 | 915 | 0.150 |
Why?
|
Guanosine Triphosphate | 1 | 2018 | 313 | 0.150 |
Why?
|
Transfection | 5 | 2016 | 5743 | 0.140 |
Why?
|
Thymoma | 4 | 2007 | 185 | 0.140 |
Why?
|
Myeloproliferative Disorders | 1 | 2024 | 616 | 0.140 |
Why?
|
Erythropoiesis | 2 | 2022 | 691 | 0.140 |
Why?
|
Molecular Sequence Data | 7 | 2015 | 17594 | 0.140 |
Why?
|
Epidermodysplasia Verruciformis | 1 | 2017 | 23 | 0.140 |
Why?
|
Rhabdomyosarcoma, Alveolar | 1 | 1997 | 41 | 0.140 |
Why?
|
Cysteine Endopeptidases | 1 | 2000 | 542 | 0.140 |
Why?
|
Lymphoid Tissue | 4 | 2002 | 444 | 0.140 |
Why?
|
Immunophenotyping | 4 | 2013 | 1866 | 0.140 |
Why?
|
RNA, Messenger | 5 | 2014 | 12768 | 0.130 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2017 | 102 | 0.130 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2018 | 429 | 0.130 |
Why?
|
Pseudogenes | 2 | 2015 | 104 | 0.130 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2017 | 2054 | 0.130 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2018 | 252 | 0.130 |
Why?
|
PAX7 Transcription Factor | 1 | 2016 | 55 | 0.130 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2000 | 660 | 0.130 |
Why?
|
Pancreatic Neoplasms | 5 | 2013 | 5444 | 0.130 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2002 | 314 | 0.130 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2016 | 88 | 0.130 |
Why?
|
Immunoblotting | 3 | 2009 | 1644 | 0.130 |
Why?
|
Leukemia | 4 | 2013 | 1522 | 0.130 |
Why?
|
Thymus Gland | 2 | 2007 | 1261 | 0.120 |
Why?
|
Neutropenia | 1 | 2021 | 893 | 0.120 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 287 | 0.120 |
Why?
|
Transcription Factors | 6 | 2022 | 12131 | 0.120 |
Why?
|
Isoquinolines | 1 | 2017 | 350 | 0.120 |
Why?
|
Immunoprecipitation | 2 | 2009 | 870 | 0.120 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 230 | 0.120 |
Why?
|
Quinazolinones | 1 | 2017 | 219 | 0.120 |
Why?
|
Boron | 1 | 2015 | 38 | 0.120 |
Why?
|
Boron Neutron Capture Therapy | 1 | 2015 | 51 | 0.120 |
Why?
|
CA-125 Antigen | 1 | 1997 | 283 | 0.120 |
Why?
|
Lymphopenia | 1 | 2017 | 297 | 0.120 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1774 | 0.120 |
Why?
|
Interleukin-17 | 1 | 2021 | 921 | 0.120 |
Why?
|
Breast Neoplasms | 6 | 2023 | 21056 | 0.120 |
Why?
|
Sulfonamides | 1 | 2024 | 1984 | 0.120 |
Why?
|
Central Nervous System Neoplasms | 1 | 2023 | 916 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3655 | 0.120 |
Why?
|
Hepatocyte Growth Factor | 1 | 2016 | 268 | 0.120 |
Why?
|
Antioxidants | 1 | 2022 | 1670 | 0.110 |
Why?
|
Spleen | 4 | 2013 | 2296 | 0.110 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1510 | 0.110 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2014 | 247 | 0.110 |
Why?
|
Cell Line | 7 | 2020 | 15543 | 0.110 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2014 | 285 | 0.110 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 1560 | 0.110 |
Why?
|
Protein Binding | 3 | 2018 | 9296 | 0.110 |
Why?
|
Neoplasm Metastasis | 3 | 2015 | 4893 | 0.110 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2017 | 548 | 0.110 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2017 | 569 | 0.110 |
Why?
|
Receptors, Estrogen | 2 | 2017 | 2242 | 0.110 |
Why?
|
Rhabdomyosarcoma | 1 | 2016 | 354 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2017 | 723 | 0.110 |
Why?
|
Purines | 1 | 2017 | 615 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2008 | 561 | 0.110 |
Why?
|
Adoptive Transfer | 1 | 2016 | 827 | 0.110 |
Why?
|
Mutation, Missense | 2 | 2018 | 2589 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2535 | 0.100 |
Why?
|
Phenotype | 7 | 2024 | 16721 | 0.100 |
Why?
|
Receptors, Interferon | 2 | 2010 | 114 | 0.100 |
Why?
|
Protein Multimerization | 1 | 2018 | 959 | 0.100 |
Why?
|
Anemia | 1 | 2022 | 1511 | 0.100 |
Why?
|
Immunity, Humoral | 1 | 2017 | 605 | 0.100 |
Why?
|
Tumor Cells, Cultured | 4 | 2010 | 6113 | 0.100 |
Why?
|
DNA | 2 | 2023 | 7202 | 0.100 |
Why?
|
Polymerase Chain Reaction | 6 | 2014 | 6069 | 0.100 |
Why?
|
Nuclear Proteins | 7 | 2024 | 5783 | 0.100 |
Why?
|
Autoantibodies | 2 | 2013 | 2113 | 0.100 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 745 | 0.100 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6364 | 0.090 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2013 | 430 | 0.090 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2013 | 184 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 4562 | 0.090 |
Why?
|
Autoimmune Diseases | 1 | 2003 | 2226 | 0.090 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 2011 | 49 | 0.090 |
Why?
|
Adenine | 1 | 2017 | 994 | 0.090 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2017 | 617 | 0.090 |
Why?
|
Serine Endopeptidases | 1 | 2016 | 1024 | 0.090 |
Why?
|
Carrier Proteins | 2 | 2024 | 4913 | 0.090 |
Why?
|
Mass Spectrometry | 3 | 2007 | 2194 | 0.090 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2014 | 660 | 0.090 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 2011 | 111 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 618 | 0.090 |
Why?
|
Gene Deletion | 2 | 2016 | 2666 | 0.090 |
Why?
|
Embryonic Stem Cells | 1 | 2018 | 1241 | 0.090 |
Why?
|
Blotting, Western | 7 | 2015 | 5020 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2023 | 3584 | 0.090 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2013 | 335 | 0.090 |
Why?
|
Mice, Nude | 5 | 2011 | 3618 | 0.090 |
Why?
|
Leukocytes | 2 | 2009 | 2027 | 0.080 |
Why?
|
Female | 38 | 2024 | 396112 | 0.080 |
Why?
|
Cells, Cultured | 8 | 2015 | 18973 | 0.080 |
Why?
|
Flow Cytometry | 6 | 2014 | 5881 | 0.080 |
Why?
|
Matrix Metalloproteinase 14 | 1 | 2010 | 59 | 0.080 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2014 | 488 | 0.080 |
Why?
|
Mice, Knockout | 8 | 2022 | 14448 | 0.080 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 1 | 2009 | 69 | 0.080 |
Why?
|
Gadolinium | 1 | 2015 | 965 | 0.080 |
Why?
|
Hodgkin Disease | 2 | 2013 | 1383 | 0.080 |
Why?
|
Immunity, Cellular | 2 | 2013 | 1555 | 0.080 |
Why?
|
Genes, erbB-2 | 1 | 2010 | 160 | 0.080 |
Why?
|
Multiple Myeloma | 2 | 2005 | 5197 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1053 | 0.080 |
Why?
|
Nucleotide Deaminases | 1 | 2008 | 11 | 0.080 |
Why?
|
Hydroxymethyl and Formyl Transferases | 1 | 2008 | 18 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 3 | 2008 | 2476 | 0.080 |
Why?
|
Disease Progression | 4 | 2019 | 13632 | 0.080 |
Why?
|
RNA | 2 | 2017 | 2717 | 0.080 |
Why?
|
Biological Evolution | 1 | 2014 | 1072 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2008 | 91 | 0.080 |
Why?
|
Uterine Neoplasms | 1 | 1997 | 1421 | 0.080 |
Why?
|
Cell Cycle | 6 | 2011 | 2920 | 0.080 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2008 | 67 | 0.080 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1140 | 0.080 |
Why?
|
Fibroblasts | 5 | 2018 | 4159 | 0.070 |
Why?
|
Piperidines | 1 | 2017 | 1664 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6499 | 0.070 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2009 | 125 | 0.070 |
Why?
|
Antibodies, Neoplasm | 1 | 2009 | 282 | 0.070 |
Why?
|
Interleukin-18 | 1 | 2009 | 251 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2009 | 2900 | 0.070 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2008 | 220 | 0.070 |
Why?
|
High-Energy Shock Waves | 1 | 2008 | 33 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 703 | 0.070 |
Why?
|
S-Phase Kinase-Associated Proteins | 3 | 2002 | 84 | 0.070 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1748 | 0.070 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2013 | 1151 | 0.070 |
Why?
|
SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2007 | 43 | 0.070 |
Why?
|
Retinoblastoma Protein | 1 | 2011 | 666 | 0.070 |
Why?
|
Hematopoiesis | 1 | 2016 | 2058 | 0.070 |
Why?
|
Protein Isoforms | 3 | 2008 | 1718 | 0.070 |
Why?
|
Lymphoproliferative Disorders | 2 | 2002 | 526 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2000 | 2942 | 0.070 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2000 | 180 | 0.070 |
Why?
|
Nucleolus Organizer Region | 3 | 1996 | 25 | 0.070 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 938 | 0.070 |
Why?
|
Immunotherapy | 2 | 2016 | 4752 | 0.070 |
Why?
|
rac GTP-Binding Proteins | 1 | 2007 | 164 | 0.070 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2013 | 845 | 0.070 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 858 | 0.070 |
Why?
|
Antigens, CD | 2 | 2016 | 4025 | 0.070 |
Why?
|
Neoplasm Proteins | 3 | 2008 | 3596 | 0.070 |
Why?
|
Neovascularization, Pathologic | 3 | 2014 | 2631 | 0.070 |
Why?
|
Leukemia, T-Cell | 1 | 2006 | 102 | 0.070 |
Why?
|
Amino Acid Substitution | 2 | 2018 | 1740 | 0.070 |
Why?
|
Cell Growth Processes | 1 | 2007 | 381 | 0.070 |
Why?
|
Genome, Human | 2 | 2023 | 4448 | 0.070 |
Why?
|
Aborted Fetus | 1 | 2006 | 11 | 0.070 |
Why?
|
Incest | 1 | 2006 | 19 | 0.070 |
Why?
|
Receptor, erbB-2 | 1 | 2017 | 2593 | 0.070 |
Why?
|
Paternity | 1 | 2006 | 14 | 0.060 |
Why?
|
Osteoclasts | 1 | 2010 | 713 | 0.060 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2007 | 234 | 0.060 |
Why?
|
Chorionic Villi | 1 | 2006 | 53 | 0.060 |
Why?
|
Disease Models, Animal | 6 | 2022 | 18293 | 0.060 |
Why?
|
Microdissection | 1 | 2006 | 152 | 0.060 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2009 | 385 | 0.060 |
Why?
|
Amino Acid Sequence | 4 | 2008 | 13400 | 0.060 |
Why?
|
Immunization, Secondary | 1 | 2008 | 373 | 0.060 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2005 | 89 | 0.060 |
Why?
|
Skin | 2 | 2017 | 4489 | 0.060 |
Why?
|
K562 Cells | 1 | 2007 | 649 | 0.060 |
Why?
|
Cell Adhesion | 2 | 2010 | 3089 | 0.060 |
Why?
|
Muscle Proteins | 2 | 2001 | 1158 | 0.060 |
Why?
|
Cell Differentiation | 5 | 2022 | 11641 | 0.060 |
Why?
|
Myocarditis | 1 | 2013 | 802 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 1724 | 0.060 |
Why?
|
Interleukin-6 | 3 | 2013 | 3222 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2017 | 4405 | 0.060 |
Why?
|
Tandem Repeat Sequences | 1 | 2006 | 184 | 0.060 |
Why?
|
Myeloid Cells | 1 | 2010 | 839 | 0.060 |
Why?
|
Sarcoma | 1 | 2016 | 1802 | 0.060 |
Why?
|
Heat-Shock Proteins | 1 | 2008 | 791 | 0.060 |
Why?
|
Pyrimidines | 1 | 2017 | 3047 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2013 | 7851 | 0.060 |
Why?
|
Tropomyosin | 1 | 2024 | 103 | 0.060 |
Why?
|
Databases, Nucleic Acid | 2 | 2016 | 204 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 3 | 2013 | 1957 | 0.060 |
Why?
|
Muscular Atrophy | 1 | 2006 | 335 | 0.050 |
Why?
|
Prognosis | 5 | 2024 | 29922 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2009 | 2446 | 0.050 |
Why?
|
Dendritic Cells, Follicular | 1 | 2003 | 50 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 11868 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 691 | 0.050 |
Why?
|
STAT1 Transcription Factor | 3 | 2010 | 339 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3513 | 0.050 |
Why?
|
Antibody Formation | 3 | 2017 | 1391 | 0.050 |
Why?
|
Plasmids | 1 | 2008 | 2274 | 0.050 |
Why?
|
Microfilament Proteins | 3 | 2008 | 1130 | 0.050 |
Why?
|
Male | 24 | 2024 | 363698 | 0.050 |
Why?
|
Genomics | 2 | 2022 | 5929 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1657 | 0.050 |
Why?
|
Oligonucleotides, Antisense | 1 | 2005 | 462 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2013 | 2968 | 0.050 |
Why?
|
Transcription, Genetic | 3 | 2013 | 7599 | 0.050 |
Why?
|
Lentivirus | 1 | 2005 | 518 | 0.050 |
Why?
|
Mice, Inbred DBA | 2 | 2001 | 623 | 0.050 |
Why?
|
Cullin Proteins | 1 | 2002 | 178 | 0.050 |
Why?
|
Diabetic Nephropathies | 1 | 2008 | 969 | 0.050 |
Why?
|
Binding Sites | 1 | 2010 | 6001 | 0.050 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 2001 | 41 | 0.050 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2428 | 0.050 |
Why?
|
Gene Expression | 4 | 2020 | 7584 | 0.050 |
Why?
|
Genetic Heterogeneity | 1 | 2024 | 735 | 0.050 |
Why?
|
Reference Values | 2 | 2008 | 4908 | 0.040 |
Why?
|
Paclitaxel | 1 | 2008 | 1728 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2009 | 2570 | 0.040 |
Why?
|
Sarcoma, Kaposi | 1 | 2003 | 375 | 0.040 |
Why?
|
MicroRNAs | 1 | 2016 | 3785 | 0.040 |
Why?
|
Leukemia, Hairy Cell | 1 | 2000 | 82 | 0.040 |
Why?
|
Methotrexate | 2 | 2022 | 1722 | 0.040 |
Why?
|
Retinoblastoma-Binding Protein 1 | 1 | 2000 | 137 | 0.040 |
Why?
|
Transcription Factor DP1 | 1 | 2000 | 135 | 0.040 |
Why?
|
Fluorescent Dyes | 1 | 2008 | 1930 | 0.040 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2012 | 1314 | 0.040 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Light Chain | 1 | 1999 | 18 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2017 | 22332 | 0.040 |
Why?
|
Survival Rate | 5 | 2013 | 12795 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2019 | 47 | 0.040 |
Why?
|
E2F1 Transcription Factor | 1 | 2000 | 183 | 0.040 |
Why?
|
Choroid Plexus | 1 | 2022 | 250 | 0.040 |
Why?
|
Clonal Deletion | 1 | 1999 | 75 | 0.040 |
Why?
|
Middle Aged | 18 | 2024 | 223009 | 0.040 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2019 | 71 | 0.040 |
Why?
|
Aged | 17 | 2024 | 171117 | 0.040 |
Why?
|
E2F Transcription Factors | 1 | 2000 | 269 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2022 | 857 | 0.040 |
Why?
|
Fertility | 1 | 2004 | 768 | 0.040 |
Why?
|
Lymphocyte Activation | 3 | 2017 | 5501 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5753 | 0.040 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2006 | 1936 | 0.040 |
Why?
|
Reed-Sternberg Cells | 1 | 1999 | 78 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2000 | 372 | 0.040 |
Why?
|
Alcohol Oxidoreductases | 1 | 2019 | 164 | 0.040 |
Why?
|
Codon | 1 | 2000 | 595 | 0.040 |
Why?
|
Carcinoma, Papillary | 1 | 2004 | 788 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1999 | 287 | 0.040 |
Why?
|
Caspase 1 | 1 | 1999 | 227 | 0.040 |
Why?
|
Organ Specificity | 1 | 2023 | 1965 | 0.040 |
Why?
|
Forkhead Transcription Factors | 2 | 2021 | 1624 | 0.040 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 2 | 2009 | 42 | 0.040 |
Why?
|
Germinal Center | 1 | 2001 | 379 | 0.040 |
Why?
|
Mice, Mutant Strains | 2 | 2013 | 1745 | 0.040 |
Why?
|
Exons | 1 | 2003 | 2391 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5849 | 0.040 |
Why?
|
Phagocytosis | 1 | 2023 | 1520 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2000 | 629 | 0.040 |
Why?
|
Adult | 16 | 2024 | 223044 | 0.040 |
Why?
|
DNA Primers | 2 | 2014 | 2825 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2003 | 1106 | 0.040 |
Why?
|
Cyclins | 1 | 2000 | 598 | 0.040 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2017 | 76 | 0.030 |
Why?
|
Aged, 80 and over | 7 | 2024 | 59489 | 0.030 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 891 | 0.030 |
Why?
|
Estonia | 1 | 2016 | 56 | 0.030 |
Why?
|
SKP Cullin F-Box Protein Ligases | 2 | 2012 | 173 | 0.030 |
Why?
|
Virulence | 1 | 2021 | 1289 | 0.030 |
Why?
|
Caspase 3 | 1 | 1999 | 731 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4108 | 0.030 |
Why?
|
Cell Nucleus | 2 | 2004 | 2867 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 2012 | 2014 | 0.030 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 2016 | 47 | 0.030 |
Why?
|
Antigens, Viral | 1 | 2001 | 995 | 0.030 |
Why?
|
Thyroid Neoplasms | 2 | 2004 | 2371 | 0.030 |
Why?
|
GATA2 Transcription Factor | 1 | 2016 | 158 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 2011 | 1701 | 0.030 |
Why?
|
Chromatin | 2 | 2022 | 2980 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2010 | 792 | 0.030 |
Why?
|
Estrogens | 1 | 2023 | 1529 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10729 | 0.030 |
Why?
|
Fetal Proteins | 1 | 2016 | 99 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 3807 | 0.030 |
Why?
|
Caspases | 1 | 1999 | 880 | 0.030 |
Why?
|
MyoD Protein | 1 | 2016 | 140 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8529 | 0.030 |
Why?
|
Codon, Nonsense | 1 | 2017 | 288 | 0.030 |
Why?
|
Central Nervous System | 1 | 2023 | 1341 | 0.030 |
Why?
|
Hyperplasia | 2 | 2013 | 1144 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2003 | 2887 | 0.030 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2017 | 304 | 0.030 |
Why?
|
Leukocyte Count | 2 | 2016 | 1602 | 0.030 |
Why?
|
Receptor, erbB-3 | 1 | 2016 | 141 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 663 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2005 | 3404 | 0.030 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9525 | 0.030 |
Why?
|
Consanguinity | 1 | 2017 | 460 | 0.030 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2009 | 647 | 0.030 |
Why?
|
Microscopy, Confocal | 2 | 2015 | 1966 | 0.030 |
Why?
|
Basophils | 1 | 2016 | 392 | 0.030 |
Why?
|
Time Factors | 1 | 2016 | 40065 | 0.030 |
Why?
|
Taxoids | 1 | 2017 | 665 | 0.030 |
Why?
|
Hydrazines | 1 | 2015 | 223 | 0.030 |
Why?
|
Macrophages | 1 | 2009 | 5772 | 0.030 |
Why?
|
Survival Analysis | 4 | 2000 | 10070 | 0.030 |
Why?
|
Histones | 2 | 2015 | 2584 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3737 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2009 | 1167 | 0.030 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 2014 | 167 | 0.030 |
Why?
|
Complement System Proteins | 1 | 2017 | 715 | 0.030 |
Why?
|
Alleles | 2 | 2017 | 6897 | 0.030 |
Why?
|
Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2013 | 19 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2016 | 634 | 0.030 |
Why?
|
Isoenzymes | 2 | 2009 | 1689 | 0.030 |
Why?
|
BRCA1 Protein | 1 | 2000 | 1153 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2007 | 3111 | 0.030 |
Why?
|
Aphidicolin | 1 | 2013 | 37 | 0.030 |
Why?
|
DNA, Neoplasm | 4 | 2003 | 1742 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2000 | 2086 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1638 | 0.030 |
Why?
|
Physical Chromosome Mapping | 1 | 2013 | 183 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2017 | 1831 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1775 | 0.030 |
Why?
|
Point Mutation | 1 | 1997 | 1590 | 0.020 |
Why?
|
Cell Lineage | 2 | 2016 | 2573 | 0.020 |
Why?
|
Proteins | 1 | 2007 | 5995 | 0.020 |
Why?
|
Endothelium, Vascular | 2 | 2003 | 4427 | 0.020 |
Why?
|
Genes, ras | 1 | 1995 | 658 | 0.020 |
Why?
|
Neoplasm Staging | 3 | 2017 | 11206 | 0.020 |
Why?
|
Child, Preschool | 3 | 2024 | 42500 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 1997 | 995 | 0.020 |
Why?
|
5' Untranslated Regions | 1 | 2013 | 256 | 0.020 |
Why?
|
Drug Synergism | 1 | 2015 | 1749 | 0.020 |
Why?
|
Epigenesis, Genetic | 2 | 2016 | 3819 | 0.020 |
Why?
|
Pancreas | 2 | 2009 | 1700 | 0.020 |
Why?
|
Adenocarcinoma, Follicular | 1 | 1995 | 326 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2022 | 3141 | 0.020 |
Why?
|
Neurons | 2 | 2008 | 9525 | 0.020 |
Why?
|
Gene Order | 1 | 2011 | 164 | 0.020 |
Why?
|
Complement C3 | 1 | 2013 | 424 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2016 | 16047 | 0.020 |
Why?
|
Gangliosides | 1 | 2011 | 132 | 0.020 |
Why?
|
NF-kappa B | 1 | 1999 | 2485 | 0.020 |
Why?
|
Microsatellite Repeats | 1 | 2013 | 784 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1053 | 0.020 |
Why?
|
Bone Marrow | 1 | 2000 | 2921 | 0.020 |
Why?
|
Triazoles | 1 | 2015 | 897 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2013 | 483 | 0.020 |
Why?
|
Genes, RAG-1 | 1 | 2010 | 67 | 0.020 |
Why?
|
Receptors, Interleukin-18 | 1 | 2009 | 25 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1365 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2001 | 3690 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2010 | 214 | 0.020 |
Why?
|
Protein Stability | 1 | 2012 | 577 | 0.020 |
Why?
|
Polymorphism, Single-Stranded Conformational | 2 | 2000 | 325 | 0.020 |
Why?
|
Hippocampus | 1 | 2022 | 3775 | 0.020 |
Why?
|
Child | 4 | 2024 | 80564 | 0.020 |
Why?
|
Testis | 1 | 2013 | 780 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 651 | 0.020 |
Why?
|
Philadelphia Chromosome | 1 | 2010 | 119 | 0.020 |
Why?
|
Giant Cells | 1 | 2010 | 187 | 0.020 |
Why?
|
Pseudopodia | 1 | 2010 | 168 | 0.020 |
Why?
|
Cell Fusion | 1 | 2010 | 295 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3620 | 0.020 |
Why?
|
Leucine | 1 | 2010 | 546 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2011 | 392 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2010 | 737 | 0.020 |
Why?
|
Genes, MHC Class I | 1 | 2009 | 236 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2016 | 4618 | 0.020 |
Why?
|
CpG Islands | 1 | 2013 | 1207 | 0.020 |
Why?
|
Adolescent | 6 | 2024 | 88835 | 0.020 |
Why?
|
Dipeptides | 1 | 2010 | 387 | 0.020 |
Why?
|
Kidney Medulla | 1 | 2008 | 169 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2009 | 404 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 777 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2003 | 3733 | 0.020 |
Why?
|
bcl-Associated Death Protein | 1 | 2008 | 102 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2010 | 924 | 0.020 |
Why?
|
Phosphotyrosine | 1 | 2008 | 459 | 0.020 |
Why?
|
Rats | 3 | 2008 | 23707 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2013 | 4165 | 0.020 |
Why?
|
Liposomes | 1 | 2011 | 788 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14652 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2015 | 2394 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2012 | 1061 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2000 | 12056 | 0.020 |
Why?
|
Podophyllotoxin | 1 | 2006 | 20 | 0.020 |
Why?
|
Ubiquitination | 1 | 2012 | 996 | 0.020 |
Why?
|
Up-Regulation | 2 | 2009 | 4137 | 0.020 |
Why?
|
PC12 Cells | 1 | 2007 | 317 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2008 | 610 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2008 | 822 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2000 | 3896 | 0.020 |
Why?
|
Carbazoles | 1 | 2008 | 229 | 0.020 |
Why?
|
Indazoles | 1 | 2008 | 303 | 0.020 |
Why?
|
Immunoglobulin G | 2 | 2009 | 4528 | 0.020 |
Why?
|
Th17 Cells | 1 | 2013 | 786 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2008 | 6493 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 1999 | 4209 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4772 | 0.020 |
Why?
|
Silver Staining | 2 | 1996 | 62 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2010 | 577 | 0.020 |
Why?
|
Kidney Glomerulus | 1 | 2008 | 568 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2000 | 12509 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2008 | 564 | 0.020 |
Why?
|
Fixatives | 1 | 2006 | 90 | 0.020 |
Why?
|
Endocytosis | 1 | 2010 | 951 | 0.020 |
Why?
|
Nerve Growth Factor | 1 | 2007 | 155 | 0.020 |
Why?
|
DNA Replication | 1 | 2013 | 1433 | 0.020 |
Why?
|
Satellite Cells, Skeletal Muscle | 1 | 2006 | 124 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 3607 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2006 | 303 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54802 | 0.020 |
Why?
|
Sulfones | 1 | 2008 | 447 | 0.020 |
Why?
|
rho-Associated Kinases | 1 | 2007 | 291 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2008 | 536 | 0.020 |
Why?
|
HeLa Cells | 1 | 2011 | 3067 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5786 | 0.020 |
Why?
|
Virus Replication | 1 | 2013 | 2447 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9373 | 0.010 |
Why?
|
Deoxycytidine | 1 | 2009 | 889 | 0.010 |
Why?
|
Epistasis, Genetic | 1 | 2007 | 353 | 0.010 |
Why?
|
Keratinocytes | 1 | 2009 | 863 | 0.010 |
Why?
|
Protein Interaction Mapping | 1 | 2008 | 619 | 0.010 |
Why?
|
Paraffin Embedding | 1 | 2006 | 301 | 0.010 |
Why?
|
Tissue Fixation | 1 | 2006 | 244 | 0.010 |
Why?
|
Pancreatitis, Chronic | 1 | 2007 | 282 | 0.010 |
Why?
|
Fluorouracil | 1 | 2009 | 1648 | 0.010 |
Why?
|
Myasthenia Gravis | 1 | 2007 | 214 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2014 | 1833 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2010 | 1744 | 0.010 |
Why?
|
Chemotaxis | 1 | 2007 | 596 | 0.010 |
Why?
|
Receptor, IGF Type 1 | 1 | 2006 | 385 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9443 | 0.010 |
Why?
|
Formaldehyde | 1 | 2006 | 352 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3356 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2056 | 0.010 |
Why?
|
Horse Diseases | 1 | 2004 | 54 | 0.010 |
Why?
|
Genes, Lethal | 1 | 2004 | 224 | 0.010 |
Why?
|
PAX2 Transcription Factor | 1 | 2003 | 86 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2013 | 2210 | 0.010 |
Why?
|
Liver | 2 | 2013 | 7562 | 0.010 |
Why?
|
Estrogen Antagonists | 1 | 2003 | 150 | 0.010 |
Why?
|
Horses | 1 | 2004 | 293 | 0.010 |
Why?
|
Proteomics | 1 | 2017 | 3910 | 0.010 |
Why?
|
Retroviridae | 1 | 2005 | 847 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2010 | 3750 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2008 | 1107 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2008 | 1216 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2822 | 0.010 |
Why?
|
Peptide Synthases | 1 | 2002 | 81 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 1995 | 2567 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2009 | 1801 | 0.010 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2008 | 1118 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2008 | 1612 | 0.010 |
Why?
|
Gene Expression Regulation | 3 | 2006 | 11888 | 0.010 |
Why?
|
Neoplasm Invasiveness | 2 | 2003 | 3602 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2005 | 898 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12976 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 26346 | 0.010 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2002 | 147 | 0.010 |
Why?
|
Computational Biology | 1 | 2013 | 3559 | 0.010 |
Why?
|
Sex Offenses | 1 | 2006 | 356 | 0.010 |
Why?
|
Lasers | 1 | 2006 | 951 | 0.010 |
Why?
|
Centrosome | 1 | 2002 | 209 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2006 | 2060 | 0.010 |
Why?
|
Tyrosine | 1 | 2005 | 1428 | 0.010 |
Why?
|
Cell Membrane | 1 | 2010 | 3634 | 0.010 |
Why?
|
Codon, Initiator | 1 | 2000 | 50 | 0.010 |
Why?
|
Circular Dichroism | 1 | 2000 | 331 | 0.010 |
Why?
|
Astrocytes | 1 | 2008 | 1345 | 0.010 |
Why?
|
bcl-X Protein | 1 | 2002 | 414 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 256 | 0.010 |
Why?
|
Indoles | 1 | 2008 | 1839 | 0.010 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 2000 | 100 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15880 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2003 | 2266 | 0.010 |
Why?
|
Nanoparticles | 1 | 2011 | 1964 | 0.010 |
Why?
|
Tamoxifen | 1 | 2003 | 963 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2000 | 8730 | 0.010 |
Why?
|
DNA Methylation | 1 | 2013 | 4424 | 0.010 |
Why?
|
Receptors, Progesterone | 1 | 2003 | 1153 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2001 | 591 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3797 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2009 | 2747 | 0.010 |
Why?
|
Cell Separation | 1 | 2003 | 1718 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41649 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2007 | 1892 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2008 | 8102 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 12807 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1997 | 772 | 0.010 |
Why?
|
Antigens, Nuclear | 1 | 1997 | 182 | 0.010 |
Why?
|
Stem Cells | 1 | 2010 | 3540 | 0.010 |
Why?
|
DNA Probes | 1 | 1997 | 541 | 0.010 |
Why?
|
Young Adult | 2 | 2014 | 59889 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2014 | 81514 | 0.010 |
Why?
|
Disabled Persons | 1 | 2006 | 1208 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2745 | 0.010 |
Why?
|
Herpesvirus 8, Human | 1 | 1997 | 254 | 0.010 |
Why?
|
Clone Cells | 1 | 1999 | 1672 | 0.010 |
Why?
|
Zinc Fingers | 1 | 1997 | 576 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4392 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22223 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2001 | 1250 | 0.010 |
Why?
|
Ploidies | 1 | 1995 | 287 | 0.010 |
Why?
|
Genes, p53 | 1 | 1996 | 711 | 0.010 |
Why?
|
Silver | 1 | 1994 | 120 | 0.010 |
Why?
|
Brain | 1 | 2000 | 27171 | 0.010 |
Why?
|
Cytokines | 1 | 2008 | 7421 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2001 | 2216 | 0.010 |
Why?
|
Protein Conformation | 1 | 2000 | 3946 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26318 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 1997 | 1078 | 0.010 |
Why?
|
Infant | 1 | 2013 | 36386 | 0.010 |
Why?
|
Cell Count | 1 | 1994 | 1823 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1994 | 1072 | 0.010 |
Why?
|
Epithelium | 1 | 1994 | 1599 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2000 | 4247 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2002 | 3401 | 0.010 |
Why?
|
Kidney | 1 | 2004 | 7066 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2004 | 8923 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1995 | 6203 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2003 | 9249 | 0.000 |
Why?
|
Lung | 1 | 2004 | 10033 | 0.000 |
Why?
|
Forecasting | 1 | 1994 | 2936 | 0.000 |
Why?
|
Inflammation | 1 | 2004 | 10850 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 1996 | 15398 | 0.000 |
Why?
|
Age Factors | 1 | 1994 | 18380 | 0.000 |
Why?
|